CAS NO: | 2138498-18-5 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | diABZISTINGagonist-1 Tautomerism (compound 3) is a selective stimulator of interferon genes(STING)receptor agonist, with EC50s of 130, 186 nM for human and mouse, respectively. | ||||||||||||||||||||||||
IC50& Target | EC50: 130 nM (human STNG in PBMCs)[1]. | ||||||||||||||||||||||||
体外研究 (In Vitro) | diABZI STING agonist-1 (Tautomerism) is a selective stimulator of interferon genes (STING) receptor agonist, with EC50s of 130, 186 nM for human and mouse, respectively. At a concentration of 1 μM, diABZI STING agonist-1 (compound 3) demonstrates high selectivity against more than 350 kinases tested[1]. | ||||||||||||||||||||||||
体内研究 (In Vivo) | diABZI STING agonist-1 (Tautomerism) (subcutaneous injection; 2.5 mg/kg) induces STING-dependent activation of type-I interferon and pro-inflammatory cytokines in vivo[1].diABZI STING agonist-1 (Tautomerism) (intravenous injection; 3 mg/kg) exhibits systemic exposure with a half-life of 1.4 h and achieves systemic concentrations greater than the half-maximal effective concentration (EC50) for mouse STING (200 ng/ml)[1].diABZI STING agonist-1 (Tautomerism) (intravenous injection; 1.5 mg/kg; 43 days) results in significant tumour growth inhibition and significantly improves survival (P < 0.001) with 8 out of 10 mice remaining tumor free at the end of the study on day 43[1].
| ||||||||||||||||||||||||
分子量 | 849.94 | ||||||||||||||||||||||||
Formula | C42H51N13O7 | ||||||||||||||||||||||||
CAS 号 | 2138498-18-5 | ||||||||||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |